




Searching News Database: Nycomed
HSMN NewsFeed - 6 Oct 2017
Norbert Oppitz Joins Sobi(TM) as New Senior Vice President, Specialty Care
Norbert Oppitz Joins Sobi(TM) as New Senior Vice President, Specialty Care
HSMN NewsFeed - 23 Jun 2014
Barry Lederman Appointed Vice President and Chief Financial Officer of Eisai Inc.
Barry Lederman Appointed Vice President and Chief Financial Officer of Eisai Inc.
HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
HSMN NewsFeed - 12 Jun 2013
Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix(R) Patent
Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix(R) Patent
HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
HSMN NewsFeed - 22 Jun 2012
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
HSMN NewsFeed - 14 Mar 2012
FDA Approves BINOSTO(TM), First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
FDA Approves BINOSTO(TM), First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
HSMN NewsFeed - 29 Feb 2012
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
HSMN NewsFeed - 18 Jan 2012
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
HSMN NewsFeed - 5 Dec 2011
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 14 Jun 2011
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
HSMN NewsFeed - 19 May 2011
Nycomed's US Dermatology Business to Become an Independent Entity Following Nycomed's Acquisition by Takeda
Nycomed's US Dermatology Business to Become an Independent Entity Following Nycomed's Acquisition by Takeda
HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
HSMN NewsFeed - 26 Apr 2010
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
HSMN NewsFeed - 19 Feb 2010
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
HSMN NewsFeed - 17 Dec 2009
Sepracor Granted Patent Term Extension for LUNESTA(R) and Provides Update on LUNESTA Pediatric Studies
Sepracor Granted Patent Term Extension for LUNESTA(R) and Provides Update on LUNESTA Pediatric Studies
HSMN NewsFeed - 22 Sep 2009
Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
HSMN NewsFeed - 11 Sep 2009
Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
HSMN NewsFeed - 7 May 2009
Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
HSMN NewsFeed - 23 Feb 2009
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
HSMN NewsFeed - 24 Sep 2008
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
HSMN NewsFeed - 29 Aug 2008
Pharmaderm Annnounces the Arrival of KEROL(TM) ZX and KEROL(TM) Emulsion to Market
Pharmaderm Annnounces the Arrival of KEROL(TM) ZX and KEROL(TM) Emulsion to Market
HSMN NewsFeed - 17 Jun 2008
The Medicines Company Hires Glyn R. Parkin as Senior Vice President, International Operations
The Medicines Company Hires Glyn R. Parkin as Senior Vice President, International Operations
HSMN NewsFeed - 3 Jun 2008
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
HSMN NewsFeed - 1 May 2008
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
HSMN NewsFeed - 1 Feb 2008
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
HSMN NewsFeed - 22 Jan 2008
Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
HSMN NewsFeed - 14 Dec 2007
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
HSMN NewsFeed - 30 Oct 2007
Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
HSMN NewsFeed - 19 Sep 2007
PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
HSMN NewsFeed - 12 Sep 2007
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
HSMN NewsFeed - 11 Jun 2007
Progen Expands Senior Management Team with Addition of Two Biopharmaceutical Industry Veterans
Progen Expands Senior Management Team with Addition of Two Biopharmaceutical Industry Veterans
HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
HSMN NewsFeed - 20 Sep 2006
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
Additional items found! 29

Members Archive contains
29 additional stories matching:
Nycomed
(Password required)
Nycomed
(Password required)